EASE: The Materna Prep Pivotal Study

Last updated: October 17, 2023
Sponsor: Materna Medical
Overall Status: Active - Recruiting

Phase

N/A

Condition

Genitourinary Prolapse

Labor/delivery

Treatment

Standard of Care (SOC)

Materna Prep Device

Clinical Study ID

NCT03973281
MaternaMedical
  • Ages > 18
  • Female

Study Summary

This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery.

Subjects are randomized to Materna Prep Device or Standard of Care without use of the Materna Prep Device

Intervention with the Materna Prep Device is expected to be a one-time use of approximately 30-90 minutes during the 1st stage of labor.

Subject participation in the study is targeted to be 12 months from the time of the use of the device during delivery.

Eligibility Criteria

Inclusion

Inclusion Criteria: Criteria for inclusion

  1. Subject is scheduled for vaginal birth.
  2. Subject is gestating a single fetus.
  3. Subject is nulliparous, or had a previous pregnancy terminated within 24 weeksgestation.
  4. Subject is able and willing to comply with the protocol required follow-up visits.
  5. Subject is able and willing to provide written informed consent prior to enrollment.
  6. In the opinion of the Investigator, the subject has sufficient mental capacity tounderstand the informed consent form (ICF), comply with the protocol requirements, andprovide clinically relevant and reliable feedback regarding their experience with thedevice.
  7. Subject receives epidural anesthesia during labor prior to enrollment.
  8. Subject is 18 years of age or older at time of consent.

Exclusion

Exclusion Criteria: Criteria for exclusion

  1. Subject has high likelihood of less than 1 hour of potential device dilation timeafter she arrives at the hospital.
  2. Subject is planning or requires a Caesarean-section prior to randomization.
  3. Subject begins labor with less than 36 weeks gestation.
  4. Subject has a neurological disorder that could cause pelvic floor dysfunction, such asmultiple sclerosis or spinal cord injury.
  5. Subject has a collagen-associated disorder that affects tissue elasticity, such asscleroderma or Ehlers-Danlos syndrome.
  6. Subject has a localized (genital tract) or systemic infection.
  7. Subject has a medical history which could lead to pelvic floor dysfunction, such asprior pelvic fractures, pelvic soft tissue injuries, or vaginal surgery.
  8. Subject has any general health condition or systemic disease that may represent, inthe opinion of the Investigator, a potential increased risk associated with device useor pregnancy.
  9. Subject has placenta previa or vasa previa.
  10. Subject has known significant chromosomal or structural fetal anomalies.
  11. Subject has a category 2 and/or 3 fetal tracing that is unresolved.
  12. Subject is observed to have friable, denuded, or markedly edematous vaginal tissueduring the course of labor.

Study Design

Total Participants: 450
Treatment Group(s): 2
Primary Treatment: Standard of Care (SOC)
Phase:
Study Start date:
December 11, 2019
Estimated Completion Date:
December 30, 2024

Study Description

Vaginal delivery is a major risk factor for pelvic floor dysfunction. Clinical aspects of pelvic floor dysfunction include pelvic organ prolapse, sexual dysfunction, and fecal and urinary incontinence. Trauma to the pelvic structures occurs as the fetal head passes through the vaginal canal, especially with acute distension at the time of crowning - the exiting of the fetal head.

The Materna Prep Device is a single-use, semi-automated dilator used during the first phase of labor in order to prepare the vaginal canal for vaginal delivery. By slowly pre-stretching the vagina and surrounding pelvic tissues during labor, the device is essentially dictating the strain rate of the tissue during labor. In previous feasibility studies, the elastic recovery of the tissue has been shown to be on the order of several hours, allowing the benefits of pre-stretching the vagina and surrounding pelvic tissues to last throughout labor. The device is intended to be removed prior to the initiation of the second stage of labor, for delivery to occur unobstructed.

The target patient population for this study is nulliparous women entering the first phase of labor and scheduled for vaginal delivery with an epidural.

Connect with a study center

  • University of Alabama at Birmingham

    Birmingham, Alabama 35233
    United States

    Site Not Available

  • MarinHealth/La Follette Ob-Gyn and Aesthetics

    Greenbrae, California 94904
    United States

    Site Not Available

  • University of California Los Angeles

    Los Angeles, California 90095
    United States

    Active - Recruiting

  • El Camino Hospital

    Mountain View, California 94040
    United States

    Site Not Available

  • Christiana Care - Center for Women's & Children's Health

    Newark, Delaware 19718
    United States

    Active - Recruiting

  • Mayo Clinic

    Rochester, Minnesota 55905
    United States

    Site Not Available

  • The Cooper Health System

    Camden, New Jersey 08103
    United States

    Active - Recruiting

  • Rutgers Robert Wood Johnson University Hospital

    New Brunswick, New Jersey 08901
    United States

    Active - Recruiting

  • Rutgers New Jersey Medical School

    Newark, New Jersey 07103
    United States

    Active - Recruiting

  • Columbia University Irving Medical Center

    New York, New York 10032
    United States

    Active - Recruiting

  • The Metro Health System

    Cleveland, Ohio 44109
    United States

    Active - Recruiting

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio 43210
    United States

    Active - Recruiting

  • Oregon Health and Science University

    Portland, Oregon 97239
    United States

    Terminated

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania 19140
    United States

    Active - Recruiting

  • Lewis Katz School of Medicine at Temple

    Philadelphia, Pennsylvania 19140
    United States

    Site Not Available

  • Baylor College of Medicine

    Houston, Texas 77030
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.